Cemaletin Nevber - NY New York, New York City 10022

Cemaletin Nevber entered the industry of Primary Care Centers in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Primary Care Centers. For further clarification, the SIC classifies this business under the code 8011 and described it as a Primary Care Centers. The business provides service to the B2C market.

To acquire more information, please contact Denise Monahan by calling (212) 583-2899 during business hours. You can also write to the business’ Single Location at 110 East 59th St Room 9b, New York City, New York NY 10022. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Cemaletin Nevber
Representative: Denise Monahan
Place of Business: 110 East 59th St Room 9b, New York City, NY 10022
Contact Number: (212) 583-2899
Type of Service: Primary Care Centers
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2010
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Cemaletin Nevber is a company operating from New York, New York providing professional Primary Care Centers and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Primary Care Centers, and with the NAICS code 6211110 as Primary Care Centers.

With a current employee count of 1 to 4, Cemaletin Nevber has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Denise Monahan at (212) 583-2899 for related queries, or to locate its Single Location using the coordinates 40.762657,-73.96934.

The Single Location can also be found at the street address 110 East 59th St Room 9b in New York City, New York 10022 and can be engaged online through the company website at , the company Twitter , and Facebook page .